KINISKA PHARMACEUTIC
(G5269C101)
ファンドの報告 KINISKA PHARMACEUTIC 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Baker BROS Advisors LP | 2,799,577 | $37,906k | Jun 30, 2019 | Aug 14, 2019 | |
| Deerfield Management Company LP Series C | 1,310,259 | $17,741k | Jun 30, 2019 | Aug 14, 2019 | |
| Sofinnova Ventures Inc | 922,700 | $12,493k | Jun 30, 2019 | Aug 13, 2019 | |
| VIVO Capital LLC | 843,478 | $11,421k | Jun 30, 2019 | Aug 13, 2019 | |
| First Manhattan Co | 63,976 | $866k | Jun 30, 2019 | Aug 16, 2019 | |
| Eventide Asset Management LLC | 37,807 | $512k | Jun 30, 2019 | Aug 14, 2019 | |
| Point72 Asset Management LP | 35,000 | $474k | Jun 30, 2019 | Aug 14, 2019 | |
| Spark Investment Management LLC | 20,800 | $281k | Jun 30, 2019 | Aug 12, 2019 | |
| Prelude Capital Management LLC | 425 | $6k | Jun 30, 2019 | Aug 14, 2019 |